AMSbio Launch Metabolism Stress Test Kits

These measurements are easily performed in standard microplates using AMSBIO's MitoXpress® Xtra Oxygen Consumption Assay

Written byAMSbio
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
AMSBIO announces the launch of two new microplate-based metabolism stress kits enabling characterization of the main parameters of mitochondrial function in live cells and evaluation of the glycolytic response of in vitro cell models to metabolic stress.
Oxygen Consumption measurements have become a key functional readout of cell metabolism and mitochondrial function, providing important insights into the cell function and role of perturbed metabolism in disease progression. These measurements are easily performed in standard microplates using AMSBIO's MitoXpress® Xtra Oxygen Consumption Assay.
While measurements of basal Oxygen Consumption alone are very informative, additional information can be gleaned from assessing parameters such as basal respiration, maximal respiration, spare respiratory capacity as well as ATP-coupled, non-ATP coupled and non-respiratory oxygen consumption. These parameters are now conveniently measurable on conventional fluorescence plate readers with the new MitoXpress® Stress Test kit from AMSBIO. Designed for use in combination with MitoXpress® Xtra Oxygen Consumption Assay, the MitoXpress® Stress Test contains all metabolic modulators required to characterise the main parameters of mitochondrial function in live cells. Compounds are provided pre-weighed for convenient handling and reproducibility. A detailed protocol is provided to facilitate easy and reproducible data generation and interpretation.
Glycolysis is a critical ATP generating pathway in eukaryotic cells and plays a central role in numerous pathologies including cancer, diabetes, autoimmune and neurodegenerative diseases. The ability to conveniently characterise the glycolytic profile of in vitro cell models used in these disease areas and to determine how specific stress interventions (e.g. nutrient deprivation, hypoxia, drug treatment) impact that profile is therefore of considerable interest.
The new pH-Xtra Stress Test from AMSBIO has been designed for use as a companion kit to their pH-Xtra Glycolysis Assay and contains all the additional components necessary for the evaluation of the glycolytic response of in vitro cell models to metabolic stress. It contains a measurement buffer tablet and glucose to allow the convenient adjustment of glucose availability, 2-deoxyglucose as a glycolysis inhibitor and oligomycin, an inhibitor of respiration driven ATP-generation to trigger maximum glycolytic activity.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery